SHARDACROP: Q2 growth was broad-based, while H2 recovery underpins unchanged FY27 guidance
NiveshIQ
NSE: SHARDACROP · Chemicals
Sharda Cropchem Ltd.
₹684.80▲ ₹19.75 (+2.97%)
Price Chart · Daily closes
1Y
6M
3M
1M
1W
1D
⚡ Intelligence Signals
5 active
🟢 Bullish Earnings Catalyst
📊 RS Laggard (5D)
🔄 Sector Sweep
⚡ Signals Aligned
📉 Pullback
NiveshIQ has detected 5 active signals on SHARDACROP. Sign up free to see what each signal means and how it affects the stock.
Unlock signals — freeExpected Move
1D / 1W / 1M range derived from news, fundamentals & technicals
1 Day
±1.8%
1 Week
±4.2%
1 Month
±9.6%
Confidence Score
Based on historical directional & magnitude accuracy for this stock
74
/ 100
About Sharda Cropchem Ltd.
Sharda Cropchem Limited is a diversified chemical manufacturer operating through Agrochemicals and Non‑Agrochemicals segments, supplying insecticides, fungicides, herbicides, veterinary drugs, and industrial chemicals such as dyes and water‑treatment reagents. The company’s agrochemical portfolio includes key active ingredients like dithianon, metalaxyl, propiconazole, and pendimethalin, while its non‑agro arm produces conveyor belts and biocides for industrial use. In FY27 Q2, consolidated revenue rose 13% to ₹1,051 cr, driven by strong non‑agro sales and Latin‑American growth that offset weaker European agro demand. EBITDA expanded 18% to ₹644 cr, reflecting margin improvement amid volume pressure. Sharda Cropchem maintains a competitive position with a broad product range and a global d
Financial Highlights
| Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹3,163 Cr -21.81% | ₹4,320 Cr +36.57% | ₹5,268 Cr +21.94% |
| EBITDA Margin | 8.94% | 13.79% | 20.43% |
| Net Profit | ₹31.88 Cr -90.68% | ₹304.38 Cr +854.67% | ₹680.86 Cr +123.69% |
| EPS | ₹3.53 | ₹33.74 | ₹75.47 |
Annual figures in Indian Rupees (Crores). Source: company filings (NSE).
Recent News
Sharda Cropchem Q2 FY27 slides: margins expand amid volume pressure By Investing.com
Sharda Cropchem Reports Strong Q2 FY27 Performance; Revenue Grows 13% and EBITDA Rises 18%
🔒
+ 3 more stories about Sharda Cropchem Ltd.
Full news feed with AI impact summaries, synced in real time.
Sign up free — it's instantStrategic Outlook
- Q2FY27 results: revenue ₹1, 052 Cr, PAT ₹92 Cr, EPS ₹10.17, EBITDA margin 15.6%. Growth context: revenue YoY +13.2%, PAT YoY +23.5%, revenue QoQ -2.1%, PAT QoQ +4.3%.
Investors should closely track demand dynamics, execution efficiency, and margin discipline over the next 2–4 quarters, ...
FY26 (last completed FY): revenue ₹5, 268 Cr, PAT ₹681 Cr, EBITDA margin 20.4%, EPS ₹75.47. Year-on-year: revenue YoY +2...
🔒
+ 3 more outlook points
Growth drivers, key risks, and upcoming catalysts — unlocked free.
Sign up free — it's instantMore Chemicals stocks
Everything you unlock with a free account
⚡Intelligence Signals — AI-detected patterns across news, earnings & technicals
📈Price Chart — 1D to 1Y daily closes for SHARDACROP
🎯Expected Move — 1D / 1W / 1M range from news, fundamentals & technicals
🧠Confidence Score — Historical directional & magnitude accuracy for this stock
🎙Analyst Target Price — Consensus target with buy / hold / sell breakdown
📰Full News Feed — All stories synced in real time with AI impact summaries
🔭Strategic Outlook — Growth drivers, risks & upcoming catalysts
📊Watchlist & Portfolio — Track SHARDACROP alongside your other holdings
Unlock full SHARDACROP research — free
No credit card · No trial · Always free to start
Frequently Asked Questions
What AI signals does NiveshIQ provide for Sharda Cropchem Ltd.?
NiveshIQ detects active intelligence signals for Sharda Cropchem Ltd. (SHARDACROP) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.
What are the key financials for Sharda Cropchem Ltd.?
Sharda Cropchem Ltd. operates in the Chemicals sector with a market capitalisation of ₹1,015,882.8L Cr. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.
Does NiveshIQ provide investment advice?
No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.